Men with nonseminomatous germ cell tumors (NSGCTs) who are at high risk of metastasis can benefit from retroperitoneal lymph node dissection (RPLND) as primary treatment, a recent study from Harvard ...
On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary retroperitoneal lymph node dissection (RPLND) ...
SAN FRANCISCO — Retroperitoneal lymph node dissection (RPLND) could potentially be a first-line option for men with stage II A/B testicular seminoma in order to reduce long-term toxicity and secondary ...
With great interest, we have read an article by Daneshmand et al 1 describing outcomes after retroperitoneal lymph node dissection (RPLND) for testicular seminoma with limited retroperitoneal ...
Post-operative recovery and length of hospital stay are critical things to consider when having major surgery. A drug commonly given to reduce the side effects of strong post-surgery pain medications ...
In patients with intermediate-risk or high-risk nonseminomatous testicular germ cell tumors (GCTs), adjunctive surgery is necessary. At some institutions, standard therapy includes four cycles of ...
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results